Skip to main content
. 2019 Apr 19;60(5):423–428. doi: 10.3349/ymj.2019.60.5.423

Table 1. Patient Clinical Characteristics.

Sustained RBBB (n=10, 19.6%) Newly developed RBBB (n=13, 25.5%) Sustained non-RBBB (n=28, 54.9%) p value
Donor data
 Male sex 9 (90) 7 (53.8) 17 (60.7) 0.147
 Age (yr) 30.4±9.5 38.0±10.5 32.7±11.5 0.223
 Body surface area (m2) 1.76±0.17 1.74±0.17 1.76±0.17 0.690
 Preoperative LVEF (%) 64.9±6.9 59.7±6.1 62.7±6.7 0.180
 Cause of death on donor 0.117
  Hypoxic brain damage 2 (20.0) 3 (23.1) 9 (32.1)
  Non-traumatic brain hemorrhage 6 (60.0) 2 (15.4) 4 (14.3)
  Traumatic brain hemorrhage 2 (20.0) 7 (53.8) 14 (50.0)
  Others 0 (0.0) 1 (7.7) 1 (3.6)
Recipient data
 Male sex 5 (50.0) 9 (69.2) 16 (57.1) 0.596
 Age (yr) 38.3±16.0 44.9±14.5 41.5±15.1 0.583
 Body surface area (m2) 1.65±0.25 1.71±0.23 1.68±0.19 0.470
 Preoperative LVEF (%) 23.9±9.9 25.6±9.0 22.2±14.0 0.694
 Total ischemic time (min) 163.7±53.6 159.0±36.9 145.7±36.5 0.401
 Previous open-heart surgery history 3 (30.0) 7 (53.8) 6 (21.4) 0.125

LVEF, left ventricular ejection fraction; RBBB, right bundle branch block.

Values are presented as n (%) or mean±SD.